Finance

Beta
Lists
SBTX:LON
Skinbiotherapeutics PLC
GBX 9.70
0.00%
(0.00) 1D
May 21, 6:42:39 AM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for SBTX...
Mkt. cap
25.14M
Avg. vol.
304.00
Volume
0.00
52-wk high
GBX 23.00
52-wk low
GBX 5.00
EPS
-GBX 0.00
Shares outstanding
259.17M
No. of employees
41
Mkt. cap
25.14M
Avg. vol.
304.00
Volume
0.00
52-wk high
GBX 23.00
52-wk low
GBX 5.00
EPS
-GBX 0.00
Shares outstanding
259.17M
No. of employees
41
News stories
From sources across the web
About Skinbiotherapeutics PLC
CEO-
Employees41
Founded2015
Headquarters-
SectorBiotechnology
Websiteskinbiotherapeutics.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
788.27K
788.27K
1.53M
1.53M
Cost of goods sold
349.48K
349.48K
539.95K
539.95K
Cost of revenue
349.48K
349.48K
539.95K
539.95K
Research and development expenses
6.08K
6.08K
57.59K
57.59K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
950.47K
950.47K
977.06K
977.06K
Operating expense
956.56K
956.56K
1.03M
1.03M
Total operating expenses
1.31M
1.31M
1.57M
1.57M
Operating income
-517.78K
-517.78K
-43.79K
-43.79K
Other non operating income
-
-
-
-
EBT including unusual items
-520.65K
-520.65K
163.09K
163.09K
EBT excluding unusual items
-520.65K
-520.65K
-86.91K
-86.91K
Income tax expense
-3.60K
-3.60K
-5.83K
-5.83K
Effective tax rate
0.69%
0.69%
-3.58%
-3.58%
Other operating expenses
-
-
-
-
Net income
-517.05K
-517.05K
168.92K
168.92K
Net profit margin
-65.59%
-65.59%
11.03%
11.03%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.88K
-2.88K
-43.12K
-43.12K
Net interest expenses
-2.88K
-2.88K
-43.12K
-43.12K
Depreciation and amortization charges
-
-
-
-
EBITDA
-449.52K
-449.52K
40.15K
40.15K
Gain or loss from assets sale
-
-
14.10K
14.10K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer